ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · IEX Real-Time Price · USD
6.15
-0.46 (-6.96%)
At close: Jul 19, 2024, 4:00 PM
6.22
+0.07 (1.14%)
Pre-market: Jul 22, 2024, 7:18 AM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $320.42 million as of July 22, 2024. Its market cap has increased by 23.86% in one year.
Market Cap
320.42M
Enterprise Value
172.68M
1-Year Change
23.86%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.04B to $320.42M, a decrease of -69.23%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 320.40M | -56.81% |
| Dec 29, 2023 | 741.80M | 61.51% |
| Dec 30, 2022 | 459.30M | -47.23% |
| Dec 31, 2021 | 870.30M | -72.79% |
| Dec 31, 2020 | 3.20B | 207.18% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 326.44M |
| Spok Holdings | 325.55M |
| Black Diamond Therapeutics | 323.45M |
| Amarin Corporation | 322.35M |
| Zynex | 320.93M |
| Scilex Holding Company | 316.18M |
| Solid Biosciences | 315.48M |
| DocGo | 313.84M |